Accord Healthcare’s Pelgraz could become the first pegfilgrastim biosimilar ... pegylated granulocyte-colony stimulating factor (G-CSF), a type of growth factor that stimulates bone marrow ...

Biocon Biologics has gained approval from the US Food and Drug Administration (FDA) for the intravenous use of Jobevne ...

Biocon Biologics has received the Food and Drug Administration’s green light for Jobevne (bevacizumab-nwgd), a biosimilar ...

Biocon Biologics Ltd today announced that the U.S. FDA has approved Jobevne™ (bevacizumab-nwgd), a biosimilar Bevacizumab for ...

Biocon's stock price increased almost 4 per cent in the early trading session on 11 April after the company’s subsidiary ...

Biocon Biologics (BBL), a subsidiary of Biocon, today announced that the U.S. Food and Drug Administration (U.S. FDA) has approved Jobevne (bevacizumab-nwgd), a biosimilar Bevacizumab for intravenous ...

Bengaluru: Biocon Biologics Ltd (BBL), a subsidiary of Biocon Ltd, has announced that the U.S. Food and Drug Administration ...

Jobevne is a recombinant humanised monoclonal antibody which functions as a vascular endothelial growth factor inhibitor ... which includes Fulphila (Pegfilgrastim-jmdb) and Ogivri (Trastuzumab ...